List view / Grid view

Aprecia Pharmaceuticals

 

news

Aprecia’s 3D-printed Spritam now available in the US

24 March 2016 | By Victoria White

Aprecia’s Spritam (levetiracetam) tablets, for oral suspension, are now available in the US as an adjunctive therapy in the treatment of partial onset seizures, myoclonic seizures and primary generalized tonic-clonic seizures.